TORONTO, Dec. 10 /CNW/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading
provider of products and services to the global life sciences markets,
announced that the Company will report fourth quarter and year-end results on
Thursday December 13th.
The Company will also host an analyst conference call with Stephen P.
DeFalco, President and Chief Executive Officer and Douglas Prince, Executive
Vice-President Finance and Chief Financial Officer, to discuss the results
with analysts. The call will be webcast live at 9:30 am EST on December 13th.
Interested parties may access the live webcast by visiting the "Latest
News" section of the MDS home page at www.mdsinc.com and clicking on the
conference link. An audio archive of the call and the presentation slides will
also be available after the event on the "Webcasts & Presentations" page in
our "For Investors" section of the MDS website.
MDS Inc. is a global life sciences company that provides market-leading
products and services that our customers need for the development of drugs and
the diagnosis and treatment of disease. We are a leading global provider of
pharmaceutical contract research, medical isotopes for molecular imaging,
radiotherapeutics, and analytical instruments. MDS has more than 6,200 highly
skilled people in 28 countries. Find out more at www.mdsinc.com or by calling
1-888-MDS-7222, 24 hours a day.
For further information:
For further information: Investors: Sharon Mathers, Senior
Vice-President, Investor Relations and External Communications, MDS Inc.,
(416) 675-6777 x 34721, firstname.lastname@example.org; Media: Catherine Melville,
Director, External Communications, MDS Inc., (416) 675-6777 x 32265,